About Index Trending news
Lists
Pricing
Surefire Medical

Surefire Medical

Surefire Medical

First-in-class infusion systems for targeted cancer treatment maximize penetration of embolic agents and prevent backflow to non-target vessels and tissues.

Elsewhere

Contributors to this profile

Alexa global traffic share

Twitter followers

Latest funding Show all
Venture capital (Series D)
$12,800,000
Venture capital (Series B)
$18,200,000
Employees

Team size

10+
Locations
HQ
Headquarters
$12,800,000 Venture capital (Series D)
PE Hub

Surefire Medical pulls in $12.8 mln Series D

Funding Messaging